Estimating the costs attributable to a disease with application to ovarian cancer

Journal of Clinical Epidemiology

Volumn 49, Issue 1, 1996, Pages 95-103

  Etzioni, Ruth ^a   Urban, Nicole ^a   Baker, Mary ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER REGISTRY; COST; DATA BASE; FEMALE; HEALTH CARE COST; HUMAN; OVARY CANCER; PRIORITY JOURNAL;

EID: 0029970392     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(96)89259-6     Document Type: Article

References (18)

1. Hartunian NS, Smart CN, Thompson M. The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease and stroke: A comparative analysis. Am J Public Health 1980; 70: 1249-1260.
2. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. New Engl J Med 1977; 296: 716-721.
3. Russell LB. Is Prevention Better than Cure. The Brookings Institution, Washington D.C., 1986.
4. Baker MS et al. Estimating the treatment costs of breast and lung cancer. Med Care 1991; 29: 40-49.
5. Riley GF et al. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care 1995; 33: 828-841.
6. Manning WG et al. The taxes of sin. Do smokers and drinkers pay their way? J Am Med Assoc 1989; 261: 1604-1609.
7. Keeler EB et al. The external costs of a sedentary lifestyle. Am J Public Health 1989; 79: 975-981.
8. Hodgson TA. Cigarette smoking and lifetime medical expenditures. Milbank Q 1992; 70: 81-125.
9. Langberg NA, Shaked M. On the identifiability of multivariate life distribution functions. Ann Probability 1982; 10:773-779.
10. Lin DY, Feuer EJ, Etzioni R, Wax Y. Estimating Medical Costs from Incomplete Follow-up Data: II. When the cost histories are not recorded. 1995. Technical Report #139, Department of Biostatistics, University of Washington.
11. Urban N. Cost effectiveness. In: Prevention of Coronary Heart Disease (Ockene IS et al., eds.). Little, Brown and Company, Boston, Massachusetts, 1992.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958; 53:457-481.
13. Lin DY, Etzioni R. Estimating medical costs from incomplete follow-up data: I. When the cost histories are recorded. 1995. Technical Report #138, Department of Biostatistics, University of Washington.
14. Chung KL. A Course in Probability Theory. Academic Press, Orlando, Florida, 1974.
15. Potosky AL et al. Potential for cancer related health services research using a linked Medicare-Tumor registry data base. Med Care 1993; 31: 732-747.
16. Lubitz JD, Riley GF. Trends in Medicare payments in the last year of life. New Engl J Med 1993; 328: 1092-1096.
17. U.S. National Center for Health Statistics. Vital Statistics of the United States. 1992. US Department of Health and Human Services, Hyattsville, Maryland. DHHS publication No. (PHS) 93-1104.
18. Frey CM et al. Representativeness of the Surveillance, Epidemiology, and End Results Program data: Recent trends in cancer mortality rates. J Natl Cancer Inst 1992; 84: 872-877.